SCHEMBL11035947

SCHEMBL11035947

O=P(O)(O)n1cncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974928 0.85 FDPS (0.42)
SCHEMBL15070418 0.79 FDPS (0.36)
SCHEMBL8674048 0.67 LMNA (0.53)
SCHEMBL1400935 0.62
Phosphoric Acid SCHEMBL8074370 0.58 CA2 (0.33)
SCHEMBL7268279 0.58 ALDH1A1 (0.43)
Pyrimidine SCHEMBL454436 0.58 FDPS (0.34)
Pyrimidine SCHEMBL988740 0.58 FDPS (0.34)
Pyrimidine SCHEMBL4154828 0.58 FDPS (0.34)
Pyrimidine SCHEMBL4140222 0.58 FDPS (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4125875-A1 AN NK-1 RECEPTOR ANTAGONIST FOR TREATING A DISEASE SELECTING FROM SEPSIS, SEPTIC SHOCK,, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) OR MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS) NeRRe Therapeutics Limited (GB) 2023-02-08 EP disclosed
EP-0145314-A1 Antifungal triazole compound IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-06-19 EP disclosed